Protext Mobility Inc
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $2.07 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Protext Mobility Inc had its IPO on under the ticker symbol TXTM.
The company operates in the Healthcare sector and Biotechnology industry. Protext Mobility Inc has a staff strength of 0 employees.
Shares of Protext Mobility Inc opened at $0 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0 - $0, and closed at $0.
This is a -7.69% slip from the previous day's closing price.
A total volume of 1,779,433 shares were traded at the close of the day’s session.
In the last one week, shares of Protext Mobility Inc have increased by +9.09%.
Protext Mobility Inc's Key Ratios
Protext Mobility Inc has a market cap of $2.07 million, indicating a price to book ratio of 0 and a price to sales ratio of 4218.552.
In the last 12-months Protext Mobility Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Protext Mobility Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Protext Mobility Inc’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q1, Protext Mobility Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Protext Mobility Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $3.48 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Protext Mobility Inc’s profitability.
Protext Mobility Inc stock is trading at a EV to sales ratio of 2997.4559 and a EV to EBITDA ratio of -3.1747. Its price to sales ratio in the trailing 12-months stood at 4218.552.
Protext Mobility Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $2.60 million
- Total Liabilities
- $2.02 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Protext Mobility Inc ended 2023 with $2.60 million in total assets and $0 in total liabilities. Its intangible assets were valued at $2.60 million while shareholder equity stood at $583879.00.
Protext Mobility Inc ended 2023 with $0 in deferred long-term liabilities, $2.02 million in other current liabilities, 41643.00 in common stock, $-1356256.00 in retained earnings and $0 in goodwill. Its cash balance stood at $792.00 and cash and short-term investments were $0. The company’s total short-term debt was $1,253,122 while long-term debt stood at $0.
Protext Mobility Inc’s total current assets stands at $792.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $767186.00 and inventory worth $0.
In 2023, Protext Mobility Inc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Protext Mobility Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Protext Mobility Inc stock is currently trading at $0 per share. It touched a 52-week high of $0.0149 and a 52-week low of $0.0149. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Protext Mobility Inc
Similar Industry Stocks (Biotechnology)
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Boca Raton, Florida. ProText Mobility, Inc. is a subsidiary of Plandaí Biotechnology, Inc.